Control Bionics Limited
Research Control Bionics Limited (CBL.AX) on Bullrun: market cap AUD 31.50M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCBL.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Market capAUD 31.50M
- Financial periodFY2025
Valuation Snapshot
latest market cap is AUD 31.50M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | -0.02 | n/a | n/a | n/a |
| FY2024 | AUD 5.13M | -AUD 5.91M | -AUD 5.38M | 71.6% | -0.04 | AUD 980.76K | AUD 961.74K | AUD 6.27M |
| FY2023 | AUD 5.44M | -AUD 5.63M | -AUD 4.98M | 64.5% | -0.06 | AUD 935.50K | AUD 128.50K | AUD 7.15M |
| FY2022 | AUD 4.38M | -AUD 6.10M | -AUD 7.03M | 54.8% | -0.06 | AUD 5.21M | AUD 284.82K | AUD 11.92M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 31.50M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Control Bionics Limited
Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, Japan, and internationally. It offers NeuroNode Trilogy, NeuroNode Duo, and Eye-gaze Duo systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Control Bionics Limited's market cap?
Control Bionics Limited's market capitalization is AUD 31.50M.
What does Control Bionics Limited do?
Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, Japan, and internationally. It offers NeuroNode Trilogy, NeuroNode Duo, and Eye-gaze Duo systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices.